Office of the Director, National Institutes of Health; Notice of Meeting, 52155-52156 [07-4480]
Download as PDF
<![CDATA[
52155
Federal Register / Vol. 72, No. 176 / Wednesday, September 12, 2007 / Notices
Drive, MSC 7936, Bethesda, MD 20892–
7936, or call non-toll-free number 301–
435–1284 or E-mail your request,
including your address to:
AvilessantaL@NHLBI.NIH.GOV.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30-days of the date of
this publication.
Dated: September 7, 2007.
Mike Lauer,
Director, Division of Prevention and
Population Sciences, NHLBI, National
Institutes of Health.
Dated: September 7, 2007.
Suzanne Freeman,
Chief, FOIA, NHLBI, National Institutes of
Health.
[FR Doc. E7–17986 Filed 9–11–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; The Cardiovascular Health
Study (CHS)
SUMMARY: In compliance with the
requirement of section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Heart, Lung, and Blood
Institute (NHLBI), the National
Institutes of Health (NIH) will publish
periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
PROPOSED COLLECTION: Title: The
Cardiovascular Health Study. Type of
Information Request: Reinstatement.
(OMB No. 0925–0334). Need and Use of
Information Collection: This study
quantifies associations between
conventional and hypothetical risk
factors and coronary heart disease
(CHD) and stroke in people age 65 years
and older. The primary objectives
include quantifying associations of risk
factors with subclinical disease;
characterizing the natural history of
CHD and stroke; and identifying factors
associated with clinical course. The
findings provide important information
on cardiovascular disease in an older
U.S. population and lead to early
treatment of risk factors associated with
disease and identification of factors that
may be important in disease prevention.
OBM clearance is being sought for data
collection activities at only one of the
four CHS field centers (the Pittsburgh
field center), which are expected to end
on May 31, 2008. Other data collection
efforts in the CHS cohort are supported
by various non-contract funding
sources. Frequency of response: twice a
year (participants) or once per
cardiovascular disease event (proxies
and physicians); Affected public:
Individuals. Types of Respondents:
Individuals recruited for CHS and their
selected proxies and physicians. The
annual reporting burden is as follows:
Estimated Number of Respondents: 556;
Estimated Number of Responses per
respondent: 1.2; and Estimated Total
Annual Burden Hours Requested: 289.
The annualized cost to respondents is
estimated at: $14,450.
There are no capital, operating, or
maintenance costs to report.
Estimated number
of respondents
Estimated number
of responses per
respondent*
Participants ............................................................................
Physicians ..............................................................................
Participant proxies .................................................................
346
70
121
1.2
1.2
1.2
0.5
0.1
0.5
208
8
73
Total ................................................................................
537
1.2
0.45
289
Type of respondents
Average burden
hours per
response
Estimated total annual burden hours
requested
jlentini on PROD1PC65 with NOTICES
*Total for 3 years.
REQUEST FOR COMMENTS: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information will have practical utility;
(2) The accuracy of the agency’s
estimate of burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
data collection plans and instruments,
VerDate Aug<31>2005
18:43 Sep 11, 2007
Jkt 211001
contact Dr. Jean Olson, Epidemiology
Branch, Division of Prevention and
Population Sciences, NHLBI, NIH, II
Rockledge Centre, 6701 Rockledge
Drive, Suite 10018, MSC # 7936,
Bethesda, MD 20892–7936, or call 301–
435–0397 (non-toll-free number), or email your request, including your
address to: OlsonJ@nhlbi.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
PO 00000
Dated: August 29, 2007.
Mike Lauer,
Director, Division of Prevention and
Population Sciences, NHLBI, National
Institutes of Health.
Suzanne Freeman,
Chief, FOIA, NHLBI, National Institutes of
Health.
[FR Doc. E7–18012 Filed 9–11–07; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Frm 00111
Fmt 4703
Sfmt 4703
E:\FR\FM\12SEN1.SGM
12SEN1
52156
Federal Register / Vol. 72, No. 176 / Wednesday, September 12, 2007 / Notices
jlentini on PROD1PC65 with NOTICES
Office of AIDS Research Advisory
Council.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Dated: September 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4480 Filed 9–11–07; 8:45 am]
Name of Committee: Office of AIDS
Research Advisory Council.
Date: October 24, 2007.
Time: 9 AM to 5:30 PM.
Agenda: The agenda will focus on the
Prevention Research Challenges of HIV
Infection in Racial and Ethnic Communities
in the United States. An update will be
provided on the OARAC Working Groups for
Treatment and Prevention Guidelines.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892.
Contact Person: Christina Brackna,
Coordinator, Program Planning and Analysis,
Office of Aids Research, Office of the
Director, NIH, 5635 Fishers Lane MSC 9310,
Suite 4000, Rockville, MD 20852, (301) 402–
8655, cm53v@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page: www.nih.gov/
od/oar/index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
National Institutes of Health
VerDate Aug<31>2005
20:02 Sep 11, 2007
Jkt 211001
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Molecular
Oncology P01.
Date: October 2–3, 2007.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Michael B. Small, PhD,
Scientific Review Administrator, Division of
Extramural Activities, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd., Room 8127, Bethesda, MD
20892–8328, 301–402–0996,
smallm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: September 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4481 Filed 9–11–07; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group, Clinical Trials
Review Committee.
Date: October 29–30, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: InterContinental Harbor Court
Baltimore, 550 Light Street, Baltimore, MD
21202.
Contact Person: Patricia A. Haggerty, PhD,
Section Chief, Clinical Studies and Training
Scientific Review Group, Review Branch,
Division of Extramural Research Activities,
National Heart, Lung, and Blood Institute,
NIH, 6701 Rockledge Drive, Room 7194, MSC
7924, Bethesda, MD 20892, 301/435–0288,
haggertp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research, 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS.)
Dated: September 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4479 Filed 9–11–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
E:\FR\FM\12SEN1.SGM
12SEN1
]]>Agencies
[Federal Register Volume 72, Number 176 (Wednesday, September 12, 2007)]
[Notices]
[Pages 52155-52156]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4480]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the
[[Page 52156]]
Office of AIDS Research Advisory Council.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Office of AIDS Research Advisory Council.
Date: October 24, 2007.
Time: 9 AM to 5:30 PM.
Agenda: The agenda will focus on the Prevention Research
Challenges of HIV Infection in Racial and Ethnic Communities in the
United States. An update will be provided on the OARAC Working
Groups for Treatment and Prevention Guidelines.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892.
Contact Person: Christina Brackna, Coordinator, Program Planning
and Analysis, Office of Aids Research, Office of the Director, NIH,
5635 Fishers Lane MSC 9310, Suite 4000, Rockville, MD 20852, (301)
402-8655, cm53v@nih.gov.
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nih.gov/od/oar/index.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: September 5, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4480 Filed 9-11-07; 8:45 am]
BILLING CODE 4140-01-M
